Profusa, Inc.

Profusa, Inc. (PFSA) is a medical-technology company focused on continuous biosensing, developing implantable sensors designed to monitor biological chemistry — including tissue oxygen levels — in real time. The company operates in the digital health and medical device sector, positioning its platform for applications across clinical diagnostics and remote health monitoring. Profusa filed a Form 10-K annual report with the SEC on March 6, 2023, under accession number 0001213900-23-017591, reflecting its status as a U.S. reporting company. The sponsor name associated with its SPAC transaction has not been independently verified at this time. For complete filing history, deal analytics, and company data on PFSA, sign up for full access at SpacDesk.